REPOTRECTINIB vs REVEFENACIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
REPOTRECTINIB vs REVEFENACIN: Safety Overview
| Metric | REPOTRECTINIB | REVEFENACIN |
|---|---|---|
| Total FAERS Reports | 187 | 280 |
| Deaths Reported | 27 | 11 |
| Death Rate | 14.4% | 3.9% |
| Hospitalizations | 48 | 23 |
| Average Patient Age | 60.8 yrs | 72.4 yrs |
| % Female Patients | 61.1% | 59.1% |
| FDA Approval Date | Jun 11, 2024 | Nov 9, 2018 |
| Manufacturer | E.R. Squibb & Sons, L.L.C. | Viatris Specialty LLC |
| Route | ORAL | RESPIRATORY (INHALATION) |
| Marketing Status | Prescription | Prescription |